This is the authors' abstract. We don't add key points for this paper.
INTRODUCTION: Diabetes mellitus is increasingly recognised as a chronic metabolic-inflammatory disorder. Diabetic autonomic neuropathy (DAN) is a prevalent yet underdiagnosed complication associated with significant morbidity and mortality. Rather than acting solely as an end-stage downstream consequence of hyperglycemia, DAN may serve as an active driver of neuroimmune dysfunction by disrupting the inflammatory reflex and its efferent arm, the cholinergic anti-inflammatory pathway (CAP). METHODS: This review synthesises current preclinical and clinical literature examining the physiological architecture of the inflammatory reflex, the molecular mechanisms linking hyperglycemia-induced neurovascular damage to CAP failure (including α7 nicotinic acetylcholine receptor (α7nAChR) signalling), and diagnostic modalities (e.g., heart rate variability) used to evaluate autonomic-immune crosstalk. RESULTS: Evidence indicates that metabolic stress, oxidative damage, and microvascular ischemia compromise vagal structural integrity and suppress cholinergic anti-inflammatory signalling. This loss of autonomic restraint exacerbates systemic cytokine production (e.g., TNF-α, IL-6), establishing a self-perpetuating, bidirectional pathophysiological loop that accelerates both neural injury and end-organ complications. Emerging therapeutic strategies-such as exercise-induced autonomic reactivation, bioelectronic vagus nerve stimulation (VNS), and targeted α7nAChR agonists-demonstrate promising potential to interrupt this cycle and restore neuroimmune homeostasis. CONCLUSION: DAN represents a critical state of autonomic-mediated immune dysregulation rather than isolated neural damage. While causal mechanisms require further validation through prospective and interventional human trials, reframing DAN as a neuroimmune failure provides novel opportunities for precision phenotyping and targeted therapeutic interventions.
No takes yet. Share an insight, caveat, or question.
Dastmalchi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Endocrinology Diabetes & Metabolism